Lista de obras - Camilla Jandus - Dominio Público Uruguay

Alginate-coated chitosan nanogel capacity to modulate the effect of TLR ligands on blood dendritic cells

artículo científico publicado en 2013

CD127+ innate lymphoid cells are dysregulated in treatment naïve acute myeloid leukemia patients at diagnosis

artículo científico publicado en 2015

CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors

artículo científico publicado en 2020

Cancer Immunotherapy by Blocking Immune Checkpoints on Innate Lymphocytes

artículo científico publicado en 2020

Combination of transient lymphodepletion with busulfan and fludarabine and peptide vaccination in a phase I clinical trial for patients with advanced melanoma

artículo científico publicado en 2007

Distinct and shared gene expression for human innate versus adaptive helper lymphoid cells

scientific article published on 04 February 2020

Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion

artículo científico publicado en 2020

Epitope located N-glycans impair the MHC-I epitope generation and presentation

artículo científico publicado en 2015

Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8(+) T cells with detection by ELISPOT and HLA-multimer staining

artículo científico publicado en 2014

High-throughput monitoring of human tumor-specific T-cell responses with large peptide pools

artículo científico publicado en 2015

ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrence.

artículo científico publicado en 2017

Identification of innate lymphoid cells in single-cell RNA-Seq data.

artículo científico publicado en 2017

Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides

scientific article published on 01 August 2008

Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance

artículo científico publicado en 2014

Melan-A/MART-1-specific CD4 T cells in melanoma patients: identification of new epitopes and ex vivo visualization of specific T cells by MHC class II tetramers

artículo científico publicado en 2006

Modulation of mTOR Signalling Triggers the Formation of Stem Cell-like Memory T Cells

artículo científico publicado en 2016

Mutations in JAK2 and Calreticulin genes are associated with specific alterations of the immune system in myelofibrosis

artículo científico publicado en 2017

NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions

artículo científico publicado en 2016

New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site

artículo científico publicado en 2006

Optimized combinatorial pMHC class II multimer labeling for precision immune monitoring of tumor-specific CD4 T cells in patients

scientific article published on 01 May 2020

PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions

artículo científico publicado en 2021

Prognostic value of arginase-II expression and regulatory T-cell infiltration in head and neck squamous cell carcinoma

artículo científico publicado en 2012

Quantitative multiparameter assays to measure the effect of adjuvants on human antigen-specific CD8 T-cell responses

artículo científico publicado en 2010

Recent advances and hurdles in melanoma immunotherapy.

scientific article published on 07 September 2009

Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes

artículo científico publicado en 2019

Siglec-7/-9 ligands shield tumor cells from NK cell attack

artículo científico publicado en 2013

Targeting Siglecs—A novel pharmacological strategy for immuno- and glycotherapy ⬇️

artículo científico publicado el 31 de mayo de 2011

The SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells

artículo científico publicado en 2014

The Vast Universe of T Cell Diversity: Subsets of Memory Cells and Their Differentiation.

artículo científico publicado en 2017

The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis

artículo científico publicado en 2014

Tumor antigen-specific FOXP3+ CD4 T cells identified in human metastatic melanoma: peptide vaccination results in selective expansion of Th1-like counterparts

scientific article published on 06 October 2009

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis

artículo científico publicado en 2017

Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitope.

artículo científico publicado en 2016

Vaccination with long NY-ESO-1 79-108 peptide and CpG-B leads to robust activation of CD4 and CD8 T cell responses in stage III/IV melanoma patients, and a new HLA-DR7 epitope.

artículo científico publicado en 2015

Vaccination-induced functional competence of circulating human tumor-specific CD8 T-cells.

artículo científico publicado en 2011

Lista de obras de Camilla Jandus

Alginate-coated chitosan nanogel capacity to modulate the effect of TLR ligands on blood dendritic cells

CD127+ innate lymphoid cells are dysregulated in treatment naïve acute myeloid leukemia patients at diagnosis

CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors

Cancer Immunotherapy by Blocking Immune Checkpoints on Innate Lymphocytes

Combination of transient lymphodepletion with busulfan and fludarabine and peptide vaccination in a phase I clinical trial for patients with advanced melanoma

Distinct and shared gene expression for human innate versus adaptive helper lymphoid cells

Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion

Epitope located N-glycans impair the MHC-I epitope generation and presentation

Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8(+) T cells with detection by ELISPOT and HLA-multimer staining

High-throughput monitoring of human tumor-specific T-cell responses with large peptide pools

ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrence.

Identification of innate lymphoid cells in single-cell RNA-Seq data.

Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides

Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance

Melan-A/MART-1-specific CD4 T cells in melanoma patients: identification of new epitopes and ex vivo visualization of specific T cells by MHC class II tetramers

Modulation of mTOR Signalling Triggers the Formation of Stem Cell-like Memory T Cells

Mutations in JAK2 and Calreticulin genes are associated with specific alterations of the immune system in myelofibrosis

NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions

New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site

Optimized combinatorial pMHC class II multimer labeling for precision immune monitoring of tumor-specific CD4 T cells in patients

PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions

Prognostic value of arginase-II expression and regulatory T-cell infiltration in head and neck squamous cell carcinoma

Quantitative multiparameter assays to measure the effect of adjuvants on human antigen-specific CD8 T-cell responses

Recent advances and hurdles in melanoma immunotherapy.

Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes

Siglec-7/-9 ligands shield tumor cells from NK cell attack

Targeting Siglecs—A novel pharmacological strategy for immuno- and glycotherapy ⬇️

The SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells

The Vast Universe of T Cell Diversity: Subsets of Memory Cells and Their Differentiation.

The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis

Tumor antigen-specific FOXP3+ CD4 T cells identified in human metastatic melanoma: peptide vaccination results in selective expansion of Th1-like counterparts

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis

Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitope.

Vaccination with long NY-ESO-1 79-108 peptide and CpG-B leads to robust activation of CD4 and CD8 T cell responses in stage III/IV melanoma patients, and a new HLA-DR7 epitope.

Vaccination-induced functional competence of circulating human tumor-specific CD8 T-cells.